CATTANEO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 146
AS - Asia 115
EU - Europa 47
SA - Sud America 25
AF - Africa 2
Totale 335
Nazione #
US - Stati Uniti d'America 140
SG - Singapore 52
CN - Cina 23
BR - Brasile 20
VN - Vietnam 15
HK - Hong Kong 14
DE - Germania 13
RU - Federazione Russa 6
GB - Regno Unito 5
CA - Canada 4
FI - Finlandia 4
IE - Irlanda 4
EC - Ecuador 3
AR - Argentina 2
AT - Austria 2
FR - Francia 2
IT - Italia 2
PK - Pakistan 2
PL - Polonia 2
UA - Ucraina 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
DM - Dominica 1
HR - Croazia 1
ID - Indonesia 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
MA - Marocco 1
MX - Messico 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SE - Svezia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 335
Città #
Ashburn 28
Singapore 23
Beijing 15
Hong Kong 14
Fairfield 10
Wilmington 8
Houston 7
Dong Ket 6
Munich 6
Seattle 6
Woodbridge 6
Dearborn 5
Los Angeles 5
Boardman 4
Dallas 4
Dublin 4
Ho Chi Minh City 4
Princeton 4
Cambridge 3
Düsseldorf 3
Hanoi 3
Redondo Beach 3
Turku 3
Denver 2
Jacksonville 2
Montreal 2
New York 2
Ogden 2
São Paulo 2
Udine 2
Warsaw 2
Alfenas 1
Alto Paraju 1
Ann Arbor 1
Atuntaqui 1
Baltimore 1
Bandung 1
Barnaul 1
Buffalo 1
Chandler 1
Chennai 1
Chicago 1
Cidade Ocidental 1
City of London 1
Faisalabad 1
Frankfurt am Main 1
Guangzhou 1
Guayaquil 1
Haiphong 1
Hefei 1
Hải Dương 1
Iporá 1
Izmir 1
Johannesburg 1
Joinville 1
La Plata 1
Lappeenranta 1
Leme 1
London 1
Machala 1
Manila 1
Marrakesh 1
Mexico City 1
Nova Serrana 1
Nuremberg 1
Orem 1
Ottawa 1
Pentecoste 1
Philadelphia 1
Poplar 1
Porto Alegre 1
Porto Seguro 1
Quilmes 1
Roseau 1
Salalah 1
San Diego 1
Santos 1
Seoul 1
Sofia 1
Stockholm 1
Stockton-on-Tees 1
Sumaré 1
São João da Boa Vista 1
São João do Paraíso 1
São Luís 1
Tokyo 1
Tramandaí 1
Vancouver 1
Videira 1
Winston-Salem 1
Zagreb 1
Águas Lindas de Goiás 1
Totale 251
Nome #
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 113
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 62
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 60
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 59
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 59
Totale 353
Categoria #
all - tutte 1.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 4 6 2 1 1 0 7
2021/202215 0 1 0 0 0 0 1 0 0 4 5 4
2022/202310 4 0 0 0 0 4 0 0 2 0 0 0
2023/202416 2 1 0 3 1 0 0 2 2 0 1 4
2024/202597 4 7 5 1 4 4 7 6 14 8 13 24
2025/2026135 29 22 20 27 33 4 0 0 0 0 0 0
Totale 353